Fast-track concordance studies with our reliable biomarker services and Health Institution status.
Decades of experience developing and validating companion diagnostics for leading biotech and pharma clients.
A technology agnostic approach to enable an unbiased selection of the most suitable platforms.
Specialty testing in CLIA-certified, CAP accredited, and GCLP compliant service laboratories to support concurrent clinical trials and regulatory submissions.
Global standardization and harmonization of IHC assays via our Biomarker Academy™ training programs and post-approval services.
One of the largest commercial fleets of proteomics, genomics, and molecular pathology instruments –
all under one roof and laboratories on different continents to speed testing.
We routinely conduct concordance testing using our diverse, platform agnostic capabilities spanning the following technologies.
Copyright © 2025 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing
